RegulatoryJun 12, 2026, 09:01 AM
BiomX Plan to Regain NYSE American Listing Compliance Accepted
AI Summary
BiomX Inc. announced that NYSE Regulation accepted its plan to regain compliance with NYSE American listing standards, granting a plan period through September 25, 2027. The company had previously received a notice of non-compliance on March 25, 2026, due to a stockholders’ deficit of $(1.302 million) as of December 31, 2025, and sustained losses. During this period, BiomX's common stock will continue to be listed and traded on the NYSE American, and the company intends to implement its plan to meet the listing requirements.
Key Highlights
- BiomX's plan to regain NYSE American listing compliance was accepted.
- Company granted a compliance plan period through September 25, 2027.
- Previously received non-compliance notice on March 25, 2026.
- Non-compliance due to stockholders’ deficit of $(1.302 million) as of Dec 31, 2025.
- BiomX common stock will continue to be listed and traded during the plan period.
Price Impact
More from PHGE